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every 8 h plus intramuscular ceftriaxone 1 g/day for 5 more
days.
Blood cultures obtained on admission were negative, but a
culture from the ﬁnger lesion yielded a S. pyogenes strain which
showed the same antimicrobial susceptibility pattern as the
woman’s isolate. Antistreptolysin O and streptozyme test titers
were 255 Todd units and 1 : 200, respectively, on admission,
and, 4 weeks later, 310 and 1 : 400. The woman’s and surgeon’s
isolates were sent to the National Health Institute for typing.
Both strains were found to be T-andM-non-typable, producers
of serum opacity factor and protease, and negative for the genes
encoding erythrogenic toxin (speA and speC). The macro-
restriction proﬁle, studied by pulsed-ﬁeld gel electrophoresis
(PFGE) after digestion of the DNA by SmaI according to
Stanley et al [3], was identical in both strains (data not shown).
DNA macrorestriction endonuclease analysis using PFGE to
conﬁrm the spread of S. pyogenes among close contacts of
infected patients has already been used by other researchers
[4].
S. pyogenes is primarily a common agent of pharyngo-
tonsillitis, but an increasing frequency of severe invasive infec-
tions due to this pathogen, such as toxic shock syndrome (TSS),
necrotizing fasciitis, and other skin and soft tissue infections,
has been observed [5]. Healthcare workers are aware of the
occupational risk of developing HBV, HCV or HIV infection,
but bacterial pathogens such as S. pyogenes are a well-known
serious hazard in medical practice as well. In 1847, Kolletschka,
a professor of medical jurisprudence in Vienna, died of pre-
sumptive streptococcal septicemia after pricking a ﬁnger during
a necropsy on a victim of puerperal fever. In the ﬁrst decades of
this century, similar accidents have been described in surgeons,
nurses and pathologists after ﬁnger pricks or scratches during
attendance on a septic patient [6]. Much more recently, a TSS
has been observed in a ﬁre-ﬁghter exposed during prehospital
resuscitation to the secretions of an S. pyogenes-infected child
[7], and invasive infections (bullous cellulitis, ascending lym-
phangitis, necrotizing fasciitis) have been developed by phys-
icians who came in contact with body ﬂuids or secretions of
patients with streptococcal TSS [8], or who scratched a ﬁnger
with the needle used in a patient with group A streptococcal
sepsis [9].
To our knowledge, we have documented the ﬁrst invasive
streptococcal infection in a surgeon following professional
injury by a medical instrument. The case we describe dem-
onstrates that: (1) surgeons and other health workers must
adhere to the well-known isolation precautions for avoiding
transmission of viral and bacterial pathogens when caring for all
patients [10]; and (2) the availability of a plan of action to use
in the case of occupational exposure would be important for
prompt diagnosis and early aggressive therapy in order to min-
imize the clinical consequences of an invasive streptococcal
infection.
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Comparison of the Bactec 460TB system and the Bactec MGIT 960
system in recovery of mycobacteria from clinical specimens
The recent increase in tuberculosis and other mycobacterioses
all over the world [1] has led to a search for faster and more
accurate detection and identiﬁcation procedures. Despite the
great advances in direct detection with molecular biology
methods [2], culture is still fundamental for mycobacterial
detection, species identiﬁcation/conﬁrmation and drug sus-
ceptibility testing. Solid media such as Lo¨wenstein–Jensen or
Middlebrook agar have been used for such purposes, but may
take several weeks to become positive. Recently introduced
media such as the Middlebrook 7H12 (12B medium) and the
modiﬁed Middlebrook 7H9 used in MGIT (MGIT medium)
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are faster for the detection of mycobacteria [3,4]. However, the
12B medium, used in the Bactec 460TB System (Bactec
460TB), contains a radioactive substrate, is semi-automated and
carries the risk of accidental needle puncturing; the MGIT
medium is cumbersome and has a potential source of error
during the readings. For all those reasons, the introduction of
the Bactec MGIT 960 System (Bactec MGIT 960), a fully
automated, non-radiometric system, was seen as a very prom-
ising alternative for liquid culture of mycobacteria.
The above considerations and the scarcity of published data
led us to undertake a study with the purpose of comparing
Bactec 460TB and BactecMGIT 960 in relation to the recovery
rate and detection time.
In total, 330 specimens were randomly obtained from 198
patients. Most of them (73.9%) were from the respiratory tract
(221 sputum samples and 23 bronchial and bronchial–alveolar
washings); in addition, there were 30 urinary samples, 35 gastric
secretion ﬂuids, nine pleural ﬂuids and 12 miscellaneous
samples.
Contaminated samples, conﬁrmed in blood agar, were
decontaminated with the NaOH method [5]. A smear stained
with the Kinyoun method was also processed for microscopy.
The incubating media were prepared with the reagents pro-
vided and according to the manufacturers’ instructions. The
inoculated 12Bmedia were incubated at 362 1 °C for 6 weeks;
they were read on Bactec 460TB twice a week for the ﬁrst 2
weeks and weekly thereafter until the sixth week. When the
growth index was ×100, the culture was considered positive,
a Kinyoun-stained smear made and the slide examined for
the presence of acid-fast-bacilli (AFB). The inoculated MGIT
media were continuously monitored in Bactec MGIT 960 until
they became positive or the end of the testing period was
reached (42 days). When the system gave a positive signal, a
smear was made as above. The detection time was the number
of days elapsed from the inoculation of the media until they
became positive, according to the above criteria. Isolates were
identiﬁed with a DNA probe of the Accuprobe System.
In the statistical analysis, the McNemar test with the Yates
correction was performed in the study of the recovery rate.
The detection time was studied with the Wilcoxon test.
The two media yielded 33 specimens (10%) with positive
cultures for AFB; 12 of them (36.4%) were smear positive and
the remaining 21 (63.6%) were smear negative. Among the
isolates, 31 were identiﬁed as belonging to the Mycobacterium
tuberculosis complex and two to the M. avium complex. With
regard to recovery rates, theMGITmedia recovered 32 (96.9%)
isolates and the 12B media recovered 26 (78.8%) isolates
(Table 1). This difference was not statistically signiﬁcant
(P× 0.05). The mean times to detect all mycobacterial isolates
were 10.8 days (range: 3–38 days) and 13.9 days (range: 5–
35 days) for MGIT and 12B media, respectively, which was
statistically signiﬁcant (P³ 0.001). Contamination rates were
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Table 1 Detection of mycobacteria in clinical specimens
according to initial smear
Isolates recovered by:
Number of isolates MGIT 12B MGIT+12B
Positive smear
specimens 12 (36.4%) 11 11 12
Negative smear
specimens 21 (63.6%) 21 15 21
Total specimens
33 (100%) 32 (96.9%) 26 (78.8%) 33 (100%)
14.2% (47 in 330 samples) and 5.8% (19 in 330 samples) for
MGIT and 12B media, respectively, and were due to Gram-
positive cocci, Gram-negative bacilli, Gram-positive cocco-
bacilli, fungi and mixed contamination.
In our study, the recovery rate was 96.9% in Bactec MGIT
960 and 78.8% in Bactec 460TB, thus showing a better ability
of Bactec MGIT 960 to detect mycobacteria, a ﬁnding similar
to previous reports [6,7]. The use of Bactec MGIT 960 is also
favored by the results of the average detection time.
However, the contamination rate (14.2%) was the most
serious problem during the use of Bactec MGIT 960. Although
the ﬁndings are within the range reported so far [8], they still
are much higher when compared with the contamination rate
obtained with Bactec 460TB in this study (5.8%) and in a
previous report [9]. The richness of MGIT medium [10] and
factors such as the type of specimen and the time elapsed until
its laboratory processing may contribute to the contamination
rate found. An increase in NaOH concentration has been sug-
gested, but the results were still high [10]. We did not use N-
acetyl-L-cysteine/sodium hydroxide for decontamination dur-
ing this study, but its later use with Bactec MGIT 960 in our
laboratory did not improve the contamination rate, and indeed
it was slightly higher (unpublished ﬁndings). Moreover, the
contamination rate observed in Bactec 460TB during this study
was not different from the rate obtained by us in previous years,
suggesting that the use of the mucolytic agent was not crucial.
Another problem when dealing with Bactec MGIT 960 is the
frequent disagreement, albeit temporary, between the positivity
reported by the system and the lack of AFB in the smear. In
fact, in 11 cases, AFB was identiﬁed on the smears a few days
after the signal in Bactec MGIT 960 was positive. Whatever
the reasons for this (difﬁculties in collecting the AFB from the
liquid media or their ﬁxation onto the slide), the result was a
delay in providing an answer to the clinicians.
We conclude that both BactecMGIT 960 and Bactec 460TB
have similar abilities to recover mycobacteria. Bactec MGIT
960 does it a little better, is deﬁnitely faster and has the advantage
of making the reading automatically. However, it has the dis-
advantage of a higher contamination rate.
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The ﬁrst glycopeptide-intermediate Staphylococcus aureus in
Oman
Glycopeptides have become the drugs of choice for the treat-
ment of infections withmultiresistant Gram-positive pathogens.
However, certain staphylococcal strains with low-level resist-
ance to glycopeptides have increasingly been isolated from
clinical specimens [1]. We report the ﬁrst case of infection with
a glycopeptide-intermediate Staphylococcus aureus (GISA) in
Oman.
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A 50-year-old woman known to have diabetes mellitus,
who had chronic renal failure, underwent renal transplant in
October 1998. Seventeen days later, she was admitted to the
Royal Hospital, Muscat, Oman, with wound infection and
rejection. Dialysis was resumed and she was put on immuno-
suppressive drugs and antibiotics. On 9 November, she
developed a catheter-site infection with S. epidermidis and was
treated with 500 mg of vancomycin, given after each dialysis.
Ten days later, she developed a femoral catheter infection with
methicillin-resistant S. aureus (MRSA). The catheter was
removed and she was treated with 500 mg of vancomycin once
a day. Two days later, vancomycin was stopped and she was
started on 200 mg of teicoplanin once a day. On 6 December
1998 and while on teicoplanin she became septic, and blood
cultures yielded MRSA. On 16 December, teicoplanin was
changed to vancomycin. Although vancomycin was maintained
at therapeutic blood levels, blood cultures continued to yield
MRSA. After 58 days on glycopeptide therapy, the patient
showed no clinical improvement and continued to haveMRSA
bacteremia. She died on 19 January 1999.
Blood cultures were performed by Bact/Alert (Organon
Technica, NC, USA). The isolate was identiﬁed as S. aureus by
standard microbiological procedures. It was then tested for
antibiotic sensitivities by Stokes’ comparative disk diffusion
method [2] and was found to be sensitive to vancomycin and
teicoplanin and resistant to methicillin, gentamicin and fucidin.
The minimum inhibitory concentrations (MICs) of van-
comycin and teicoplanin were determined by the E test method
(AB BIODISK, Solna, Sweden) on BHI agar, used according
to the manufacturers’ instructions, and susceptibilities were
determined according to NCCLS breakpoint standards [3]. The
MIC for both vancomycin and teicoplanin was 4mg/L, which
is considered susceptible by NCCLS standards. However, when
tested at the National Reference Center of Staphylococcus,
Lyon, France, the vancomycin MIC was found to be 6mg/L
and that of teicoplanin was 8mg/L. They used the E test on
BHI agar (AB BIODISK), with an inoculum equivalent to 2
McFarland standard, and incubated for 48 h. Based on French
recommendations of the Antibiogram Committee of the
French Society of Microbiology, this strain was therefore
identiﬁed as GISA. We performed a killing curve with a van-
comycin concentration of 4mg/L in brain–heart infusion (BHI)
broth. One BHI broth containing 4mg/L of vancomycin was
inoculated with the isolate and a similar BHI broth was inocu-
lated with S. aureus NCTC 25923. The isolate was also inocu-
lated into an antibiotic-free BHI broth. The broth cultures
were incubated in a shaking water bath at 37 °C. Colony counts
were performed daily for 4 days at dilutions of 10−1–10−3 by
spreading on blood agar plates. The isolate was initially
inhibited, but resumed growth after 72 h of incubation (Figure
1). Vancomycin trough blood levels were assayed twice a week
during therapy by the ﬂuorescence polarization immunoassay
